Can You Take SYNAPSE Blend With Tirzepatide or Semaglutide?

The medications this page covers:

Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. GLP-1 prices are "from" prices because they are priced by dose. Your physician sets your directions after reviewing your intake, and they are printed on the vial.

Tirzepatide

Tirzepatide is a single peptide that activates two incretin receptors. It acts on appetite centres in the brain, slows gastric emptying and changes insulin and glucagon signalling, and the weight change reported in its trials follows from people eating less over a long period. It is not a stimulant. See what is tirzepatide.

SYNAPSE: four peptides in one vial

SYNAPSE is not a single molecule. Each dose of 0.25 mL carries a fixed split of four separately studied peptides:

Those per-dose figures are each concentration multiplied by 0.25 mL, on a U-100 insulin syringe. None of the four acts on the incretin receptors tirzepatide uses, so taking both is not a duplication. The full reference is what is the SYNAPSE blend.

This is the main practical point, and it comes from two of SYNAPSE's four components, not from Semax or Selank.

Tesamorelin pulls glucose up. Growth hormone reduces insulin sensitivity. The approved tesamorelin product's label records new-onset diabetes in 5% of treated patients against 1% on placebo, at 2 mg daily, four times the tesamorelin in a SYNAPSE dose. Growth hormone reduces insulin sensitivity while GLP-1 medications act in the other direction, which is why glucose is watched for anyone taking a tesamorelin blend with a GLP-1.

MOTS-c is described pulling the other way. In the 2015 Cell Metabolism work, MOTS-c in mice was reported to prevent age-related insulin resistance and the insulin resistance that develops on a high-fat diet. That has never been tested in people.

Tirzepatide lowers glucose. It amplifies insulin release only when glucose is high, so on its own it rarely causes low blood sugar (under 2 percent in SURPASS-2), though the risk rises with insulin or a sulfonylurea.

Nobody has measured what tesamorelin and MOTS-c do to glucose together, let alone alongside a GLP-1. In practice:

Never change your diabetes medication or either dose on your own. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

Nausea is the most common side effect of GLP-1 medications. Clinical reports on SYNAPSE are mostly injection-site reactions, but some people report nausea or light-headedness early on. Starting both in the same week makes it hard to tell which one is responsible, which is one reason to start them on different dates.

If nausea shows up after a GLP-1 dose increase, the GLP-1 is the more likely cause. Managing it is covered in GLP-1 nausea: how to manage it, and SYNAPSE's full list is in SYNAPSE blend side effects.

People sometimes come to SYNAPSE because a GLP-1 has left them feeling flat or unfocused, or because they want body composition support on top of weight change. Neither has been tested. The honest position:

• Focus and stress. Semax and Selank have no appetite mechanism, and nothing shows they change anything on a GLP-1. If the brain side is the whole goal, Semax + Selank delivers those two without tesamorelin's glucose and fluid considerations. More in can you take Semax with tirzepatide and can you take Selank with tirzepatide.
• Visceral fat. Tesamorelin is sometimes prescribed with a GLP-1 on purpose, with the GLP-1 addressing total weight and tesamorelin addressing visceral fat. A SYNAPSE dose carries 0.5 mg on weekdays, a quarter of the main trial dose. See tesamorelin vs semaglutide.
• Muscle fuel handling. MOTS-c is paired with GLP-1 medications with muscle in mind, but it has no human trials. See can you take MOTS-c with tirzepatide.

No trial shows that any of these adds weight loss on top of tirzepatide, or that the combination works better than tirzepatide alone. Protein and resistance training remain the countermeasures with the most behind them for lean mass. The wider list is in what peptides can you take with tirzepatide.

The schedules are independent. Use a separate fresh syringe for each and never draw both into one. Dosing detail is in SYNAPSE blend dosage and tirzepatide dosing chart.

Tested athletes

Tesamorelin (S2.2.4) and MOTS-c (S4.4.1) are named on the 2026 WADA Prohibited List, prohibited at all times, so SYNAPSE is prohibited in tested sport. A GLP-1 does not change that. See is SYNAPSE blend banned in sports.

Everything above applies to semaglutide. It acts at the GLP-1 receptor only, where tirzepatide acts at two, but it reduces appetite and slows gastric emptying in the same way and rarely causes low blood sugar on its own. The glucose point with tesamorelin is identical. Semaglutide and tirzepatide are never taken together. See semaglutide vs tirzepatide.

SYNAPSE has never been studied as a blend, in people or in animals, and no component has been studied alongside a GLP-1. The evidence is per component and uneven: tesamorelin has randomised placebo-controlled trials of the approved product for visceral fat in HIV-associated lipodystrophy and one 20-week cognition trial in older adults; Semax and Selank have Russian clinical work in stroke and anxiety-disorder patients, using intranasal products; MOTS-c has mouse and cell work only. Tirzepatide has a large evidence base for weight management in its approved form.

Where SYNAPSE's components stand with the FDA: tesamorelin is the active ingredient of an FDA-approved product, but compounded tesamorelin is not that product; in July 2026 the Pharmacy Compounding Advisory Committee voted to recommend adding Semax and MOTS-c to the 503A Bulks List, with the FDA's final determinations pending; Selank's nomination was withdrawn and it has never been reviewed. SYNAPSE is not an FDA-approved drug. More in SYNAPSE blend benefits.

1. Name the goal. "I feel foggy and flat since starting tirzepatide" gives your physician more to work with than a product name, and it may point to sleep, food intake or another cause first.
2. List every glucose-lowering medication. Insulin and sulfonylureas especially, and any diagnosis of diabetes or prediabetes.
3. Let your physician check for duplication. FUSION and PHYSIQ also contain tesamorelin and MOTS-c.
4. Start one thing at a time, and report what happens. Including nothing.

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and your directions printed on the vial.
5. Your care team stays reachable for side effects and questions. Refills run every 28 days, one vial per fill.

Pepti is cash-pay and does not bill insurance. Step by step: how to get SYNAPSE blend prescribed online and how to get tirzepatide prescribed online.